Furthermore, the mean decrease in accuracy identified PIGN as highly important (i.e. 3rd ranked) among the GPI-AP biosynthesis genes in predicting MDS progression risk (Figure 1C). This evidence concerns the gene PIGN and myelodysplastic syndrome.